Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4130
+0.0040 (0.98%)
At close: Feb 12, 2026, 4:00 PM EST
0.3903
-0.0227 (-5.50%)
After-hours: Feb 12, 2026, 7:49 PM EST

Ensysce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2113511418,673
Market Cap Growth
-83.41%218.52%-30.67%-95.78%-99.39%21.62%
Enterprise Value
0729112-
Last Close Price
0.418.1415.90135.0016920.0044764.92
PE Ratio
-----328929.48
PS Ratio
0.182.041.501.9132.284750.02
PB Ratio
1.083.14-5.12-1.19-13.97-2804.46
P/TBV Ratio
1.122.86----
EV/Sales Ratio
0.011.250.853.5531.66-
Debt / Equity Ratio
0.440.09-1.31-1.10-2.11-0.64
Asset Turnover
0.711.250.520.230.428.06
Quick Ratio
0.731.640.370.360.770.03
Current Ratio
1.272.420.690.560.950.05
Return on Equity (ROE)
-294.39%-585.41%----
Return on Assets (ROA)
-109.79%-101.29%-155.91%-135.76%-148.12%-206.67%
Return on Capital Employed (ROCE)
-1261.60%-198.50%1715.20%676.80%30894.50%24.20%
Earnings Yield
-816.43%-75.19%-318.25%-502.55%-25.51%0.00%
Buyback Yield / Dilution
-347.04%-362.24%-1158.33%---
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q